Retour
Fourchette du Jour
299,69 €
308,91 €
Fourchette 52 Semaines
205,87 €
495,55 €
Volume
1 494 718
Moyenne 50J / 200J
337,90 €
/
392,53 €
Clôture Précédente
306,66 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 130,2 | 0,3 |
| P/B | 51,8 | 2,9 |
| ROE % | 73,3 | 3,7 |
| Net Margin % | 8,5 | 3,8 |
| Rev Growth 5Y % | 44,8 | 10,0 |
| D/E | 1,6 | 0,2 |
Objectif de Cours des Analystes
Hold
460,50 €
+49.5%
Low: 351,00 €
High: 549,00 €
P/E Prévisionnel
45,1
BPA Prévisionnel
6,80 €
Croissance BPA (est.)
+0,0%
CA Est.
5,6 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
19,29 €
16,99 € – 23,76 €
|
11 B | 14 |
| FY2029 |
16,25 €
14,31 € – 20,01 €
|
10 B | 14 |
| FY2028 |
13,74 €
9,81 € – 20,45 €
|
8,8 B | 16 |
Points Clés
Revenue grew 44,82% annually over 5 years — strong growth
ROE of 73,28% indicates high profitability
Generating 465,38M in free cash flow
P/E of 130,21 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 20,37%
Cash machine — converts 148,33% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
44,82%
Revenue (1Y)65,19%
Earnings (1Y)N/A
FCF Growth (3Y)233,09%
Qualité
Return on Equity
73,28%
ROIC18,19%
Net Margin8,45%
Op. Margin13,51%
Sécurité
Debt / Equity
1,62
Current Ratio2,76
Interest Coverage1,99
Valorisation
P/E Ratio
130,21
P/B Ratio51,77
EV/EBITDA80,70
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 65,19% | Revenue Growth (3Y) | 42,53% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 44,82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,71B | Net Income (TTM) | 313,75M |
| ROE | 73,28% | ROA | 6,32% |
| Gross Margin | 81,77% | Operating Margin | 13,51% |
| Net Margin | 8,45% | Free Cash Flow (TTM) | 465,38M |
| ROIC | 18,19% | FCF Growth (3Y) | 233,09% |
| Safety | |||
| Debt / Equity | 1,62 | Current Ratio | 2,76 |
| Interest Coverage | 1,99 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 130,21 | P/B Ratio | 51,77 |
| P/S Ratio | 11,00 | PEG Ratio | -0,79 |
| EV/EBITDA | 80,70 | Dividend Yield | 0,00% |
| Market Cap | 40,85B | Enterprise Value | 40,48B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,71B | 2,25B | 1,83B | 1,04B | 844,29M |
| Net Income | 313,75M | -278,16M | -440,24M | -1,13B | -852,82M |
| EPS (Diluted) | 2,33 | -2,18 | -3,52 | -9,30 | -7,20 |
| Gross Profit | 3,04B | 1,92B | 1,52B | 868,60M | 704,14M |
| Operating Income | 501,58M | -176,89M | -282,18M | -785,07M | -708,65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4,97B | 4,24B | 3,83B | 3,55B | 3,64B |
| Total Liabilities | 4,18B | 4,17B | 4,05B | 3,70B | 3,06B |
| Shareholders' Equity | 789,18M | 67,09M | -220,64M | -158,22M | 588,20M |
| Total Debt | 1,28B | 2,74B | 1,31B | 1,32B | 997,59M |
| Cash & Equivalents | 1,66B | 966,43M | 812,69M | 866,39M | 819,98M |
| Current Assets | 4,05B | 3,30B | 2,98B | 2,69B | 2,81B |
| Current Liabilities | 1,47B | 1,19B | 967,79M | 767,92M | 695,71M |